MedPath

Safety Demonstration of Microneedle Insertion

Completed
Conditions
Allergic Reaction to Nickel
Interventions
Device: Gold- or silver-coated, or uncoated nickel microneedles
Registration Number
NCT02995057
Lead Sponsor
University of British Columbia
Brief Summary

Hypodermic needles are conventionally used to deliver drugs and vaccines into the muscle of humans and animals. Side effects of these needle injections are pain, bleeding, and anxiety in patients. An alternative drug and vaccine delivery method is the use of hollow microneedles, which are sub-millimeter needle-like structures. Microneedles are pain- and bleeding-free, as they do not reach the nerve-endings and blood capillaries in the skin. As a result, they are better received by patients and do not induce needle anxiety. As the investigators' microneedles are made of gold- or silver-coated, as well as uncoated nickel, the purpose of this study is to observe their biocompatibility and inertness.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Proven nickel allergy
Read More
Exclusion Criteria
  • Pregnancy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Nickel allergicGold- or silver-coated, or uncoated nickel microneedlesParticipants have proven nickel allergy
Primary Outcome Measures
NameTimeMethod
Skin reaction as measured by a contact dermatitis classification system7 days

Allergic patch-test based grading will be done according to the Wilkinson DS et al 1970 reference.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath